Glucose: an energy currency and structural precursor in articular cartilage and bone with emerging roles as an extracellular signaling molecule and metabolic regulator
- PMID: 23251132
- PMCID: PMC3523231
- DOI: 10.3389/fendo.2012.00153
Glucose: an energy currency and structural precursor in articular cartilage and bone with emerging roles as an extracellular signaling molecule and metabolic regulator
Abstract
In the skeletal system glucose serves as an essential source of energy for the development, growth, and maintenance of bone and articular cartilage. It is particularly needed for skeletal morphogenesis during embryonic growth and fetal development. Glucose is vital for osteogenesis and chondrogenesis, and is used as a precursor for the synthesis of glycosaminoglycans, glycoproteins, and glycolipids. Glucose sensors are present in tissues and organs that carry out bulk glucose fluxes (i.e., intestine, kidney, and liver). The beta cells of the pancreatic islets of Langerhans respond to changes in blood glucose concentration by varying the rate of insulin synthesis and secretion. Neuronal cells in the hypothalamus are also capable of sensing extracellular glucose. Glucosensing neurons use glucose as a signaling molecule to alter their action potential frequency in response to variations in ambient glucose levels. Skeletal muscle and adipose tissue can respond to changes in circulating glucose but much less is known about glucosensing in bone and cartilage. Recent research suggests that bone cells can influence (and be influenced by) systemic glucose metabolism. This focused review article discusses what we know about glucose transport and metabolism in bone and cartilage and highlights recent studies that have linked glucose metabolism, insulin signaling, and osteocalcin activity in bone. These new findings in bone cells raise important questions about nutrient sensing, uptake, storage and processing mechanisms and how they might contribute to overall energy homeostasis in health and disease. The role of glucose in modulating anabolic and catabolic gene expression in normal and osteoarthritic chondrocytes is also discussed. In summary, cartilage and bone cells are sensitive to extracellular glucose and adjust their gene expression and metabolism in response to varying extracellular glucose concentrations.
Keywords: articular cartilage; bone; extracellular signaling; glucose; glucose transport; glucosensing; hexokinase; osteocalcin.
Figures
Similar articles
-
Facilitative glucose transporters in articular chondrocytes. Expression, distribution and functional regulation of GLUT isoforms by hypoxia, hypoxia mimetics, growth factors and pro-inflammatory cytokines.Adv Anat Embryol Cell Biol. 2008;200:1 p following vi, 1-84. Adv Anat Embryol Cell Biol. 2008. PMID: 18841755 Review.
-
Glucose transport and metabolism in chondrocytes: a key to understanding chondrogenesis, skeletal development and cartilage degradation in osteoarthritis.Histol Histopathol. 2002 Oct;17(4):1239-67. doi: 10.14670/HH-17.1239. Histol Histopathol. 2002. PMID: 12371151 Review.
-
Neuronal glucosensing: what do we know after 50 years?Diabetes. 2004 Oct;53(10):2521-8. doi: 10.2337/diabetes.53.10.2521. Diabetes. 2004. PMID: 15448079 Review.
-
Distinct pathways regulate facilitated glucose transport in human articular chondrocytes during anabolic and catabolic responses.Am J Physiol Endocrinol Metab. 2004 Jun;286(6):E980-5. doi: 10.1152/ajpendo.00243.2003. Epub 2004 Jan 28. Am J Physiol Endocrinol Metab. 2004. PMID: 14749204
-
Hepatocyte growth factor/scatter factor is not a potent regulator of anabolic and catabolic gene expression in adult human articular chondrocytes.Biochem Biophys Res Commun. 2004 Apr 16;316(4):984-90. doi: 10.1016/j.bbrc.2004.03.001. Biochem Biophys Res Commun. 2004. PMID: 15044081
Cited by
-
In silico development and validation of a novel glucose and lipid metabolism-related gene signature in gastric cancer.Transl Cancer Res. 2022 Jul;11(7):1977-1993. doi: 10.21037/tcr-22-168. Transl Cancer Res. 2022. PMID: 35966316 Free PMC article.
-
Associations of Longitudinal Fetal Growth Patterns With Cardiometabolic Factors at Birth.Front Endocrinol (Lausanne). 2021 Dec 9;12:771193. doi: 10.3389/fendo.2021.771193. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34956083 Free PMC article.
-
Distinct metabolic programs induced by TGF-β1 and BMP2 in human articular chondrocytes with osteoarthritis.J Orthop Translat. 2018 Jan 2;12:66-73. doi: 10.1016/j.jot.2017.12.004. eCollection 2018 Jan. J Orthop Translat. 2018. PMID: 29662780 Free PMC article.
-
Circadian rhythms affect bone reconstruction by regulating bone energy metabolism.J Transl Med. 2021 Sep 27;19(1):410. doi: 10.1186/s12967-021-03068-x. J Transl Med. 2021. PMID: 34579752 Free PMC article. Review.
-
Inhibition of glucose use improves structural recovery of injured Achilles tendon in mice.J Orthop Res. 2022 Jun;40(6):1409-1419. doi: 10.1002/jor.25176. Epub 2021 Sep 8. J Orthop Res. 2022. PMID: 34460123 Free PMC article.
References
-
- Bacchetta J., Boutroy S., Guebre-Egziabher F., Juillard L., Drai J., Pelletier S., et al. (2009). The relationship between adipokines, osteocalcin and bone quality in chronic kidney disease. Nephrol. Dial. Transplant. 24 3120–3125 - PubMed
-
- Bird T. A., Davies A., Baldwin S. A., Saklatvala J. (1990). Interleukin 1 stimulates hexose transport in fibroblasts by increasing the expression of glucose transporters. J. Biol. Chem. 265 13578–13583 - PubMed
-
- Buckwalter J. A., Mankin H. J., Grodzinsky A. J. (2005). Articular cartilage and osteoarthritis. Instr. Course Lect. 54 465–480 - PubMed
-
- Burr D. B., Gallant M. A. (2012). Bone remodelling in osteoarthritis. Nat. Rev. Rheumatol. 8 665–673 - PubMed
-
- Burstein D. E., Reder I., Weiser K., Tong T., Pritsker A., Haber R. S. (1998). GLUT1 glucose transporter: a highly sensitive marker of malignancy in body cavity effusions. Mod. Pathol. 11 392–396 - PubMed
LinkOut - more resources
Full Text Sources